- জেনেরিক নাম
- Erlotinib
- শক্তি
- 150 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Synovia Pharma PLC.
৳ ৮৮২ ৳ ৯০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
Synteva 150 mg Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Erlotinib এবং শক্তি ১৫০ mg। এটি তৈরি করে Synovia Pharma PLC। Synteva 150 mg-এর প্রতি ইউনিটের দাম ৯০০ টাকা। Synteva 150 mg-এর সাথে Erlotinib-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Erlotinib-এর ২টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। ইউনিট দামের হিসেবে Synteva 150 mg এগুলোর মধ্যে সবচেয়ে কম দামিদের একটি।
Synteva 150 mg Tablet is a targeted cancer therapy. Its active ingredient is erlotinib, and it comes as a tablet in a 150 mg strength from Synovia Pharma PLC. It belongs to a group of medicines that act on specific targets in cancer cells rather than on the whole body. Doctors prescribe it for particular types of non-small cell lung cancer and, in some situations, pancreatic cancer. It is used only under the guidance of a cancer specialist, who decides whether it suits a person and how the treatment should be given.
Synteva 150 mg Tablet is used for first-line treatment of metastatic non-small cell lung cancer in people whose tumours have certain epidermal growth factor receptor mutations. It is also used as maintenance treatment for locally advanced or metastatic non-small cell lung cancer that has not progressed after a set number of cycles of platinum-based chemotherapy. In pancreatic cancer it may be used together with another cancer medicine. A specialist decides whether the medicine is suitable.
Synteva 150 mg Tablet is taken by mouth. It is usually taken on an empty stomach, at least one hour before or two hours after food. The doctor decides the dose and how long the course continues; do not change the dose yourself. If a dose is missed or vomiting occurs, ask the doctor or pharmacist what to do. Swallow the tablet as directed and keep all follow-up appointments so the treatment can be monitored.
Common side effects of erlotinib include rash, diarrhoea, loss of appetite, tiredness, shortness of breath, cough, nausea and vomiting. Some people develop serious problems, including lung inflammation, kidney problems, liver injury, bowel perforation, serious skin reactions, heart or blood vessel events, eye problems and bleeding, especially with warfarin. Tell your doctor promptly about new or worsening breathing problems, severe diarrhoea, skin changes, eye symptoms or unusual bleeding. The doctor will decide how to manage any side effect.
Synteva 150 mg Tablet is not for everyone. Tell your doctor about lung, kidney or liver problems, eye disorders, bowel problems or bleeding risk, and about all other medicines you take, because some medicines change how erlotinib works. It can harm an unborn baby and is not recommended in pregnancy; effective contraception is important during treatment. It is not known whether it passes into breast milk, so breastfeeding decisions should be discussed with the doctor. People with these concerns should ask the doctor before starting treatment.
Anyone with lung, liver, kidney, eye or bowel problems, or a bleeding tendency, should tell the doctor before starting. Pregnancy and breastfeeding need special discussion. People taking blood thinners or other medicines that interact with erlotinib should check with the doctor, who will decide whether it is suitable.
It is a targeted cancer therapy containing erlotinib. It is used for certain non-small cell lung cancers and, in some cases, pancreatic cancer. It acts on specific targets in cancer cells. A cancer specialist decides whether it is appropriate and how treatment should proceed.
Erlotinib is the generic name of the active ingredient in Synteva 150 mg Tablet. It refers to a targeted cancer medicine that blocks a specific signalling pathway in certain cancer cells. The generic name identifies the medicine itself, while Synteva is the brand name from Synovia Pharma PLC.
Some medicines can change how erlotinib works or raise the risk of side effects, including blood thinners and certain antibiotics or antifungal medicines. Always tell your doctor and pharmacist about every medicine, supplement or herbal product you use, and let them decide what is suitable.
৳ ৮৮২ ৳ ৯০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
First-line treatment of patients with metastatic Non-Small Cell Lung cancer (NSCLC) whose tumors have Epidermal Growth Factor Receptor (EGFR) exon 19 deletions or exon 21 substitution mutations as detected.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
NSCLC: The recommended daily dose of Erlotinib for NSCLC is 150 mg taken on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Anticoagulants: Interaction with coumarin-derived anticoagulants, including warfarin, leading to increased International Normalized Ratio (INR) and bleeding adverse reactions.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The most common adverse reactions (20%) with Erlotinib from a pooled analysis of studies were rash, diarrhea, anorexia, fatigue, dyspnea, cough, nausea, and vomiting. The following serious adverse reactions, which may include fatalities.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy category D. Based on its mechanism of action, Erlotinib can cause fetal harm when administered to a pregnant woman. It is not known whether Erlotinib is present in human milk. Because many drugs are present in human milk and because of the potential for serious adverse reactions in nursing infants from Erlotinib, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Single oral doses of Erlotinib up to 1,000 mg in healthy subjects and weekly doses up to 1,600 mg in cancer patients have been tolerated. Repeated twice-daily doses of 200 mg single-agent Erlotinib in healthy subjects were poorly tolerated after only a few days of dosing. Based on the data from these studies, an unacceptable incidence of severe adverse reactions, such as diarrhea, rash, and liver transaminase elevation, may occur above the recommended dose. In case of suspected overdose, Erlotinib should be withheld and symptomatic treatment instituted.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।